Moffitt Cancer Center at SouthShore is a clinical research site located in Ruskin, Florida, United States 33570.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Moffitt Cancer Center at SouthShore has participated in 8 clinical trials with 8 currently active.
Therapeutic areas: Pancreatic Carcinoma, Pancreatic Neoplasm, Oligometastatic Prostate Carcinoma.
Sponsors: SWOG Cancer Research Network, NRG Oncology, Pfizer.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Moffitt Cancer Center at SouthShore has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Moffitt Cancer Center at SouthShore has 8 clinical trials on record, with 8 currently active. Their work covers Pancreatic Carcinoma, Pancreatic Neoplasm, Oligometastatic Prostate Carcinoma.
Yes — Moffitt Cancer Center at SouthShore holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.